Hyundai Pharm to conduct clinical trial of acebrophylline in China

Published: 2013-03-14 06:56:00
Updated: 2013-03-14 06:56:00
Hyundai Pharmaceutical has recently announced the commencement of clinical trial for Surfolase (acebrophylline) capsules in China during the latter half of this year.

This clinical trial, which was accepted by the Chinese health authorities on March 5, will be undertaken from local university ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.